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Background: This examination was performed to research the advantage of the 
antioxidant impact of Potentilla fulgens on spinal cord injury (SCI) in rats. 
Materials and methods: In the SCI model of this examination, the tolerably serious 
lesion was performed at the L1–L2 spinal segmental level. SCI animals were given 
P. fulgens 400 mg/kg/day, intraperitoneally. At 7 days post-lesion, exploratory rats 
were executed after intraperitoneal administration 7 ketamine HCL (0.15 mL/100 g 
body weight). Spinal cord specimens were taken for histological examination or 
assurance of malondialdehyde (MDA) and glutathione (GSH) levels and myelope-
roxidase (MPO) action. SCI caused a remarkable decline in spinal cord GSH content, 
trailed by noteworthy increments in MDA levels and MPO action. 
Results: Degenerative changes in some multipolar and bipolar nerve cells and 
pyknotic changes in the nuclei of glial cells were likewise noticed. Remarkable 
development was seen in cells and vascular structures of P. fulgens treated groups 
when contrasted with untreated groups. 
Conclusions: Potentilla fulgens application may influence angiogenetic impro-
vement in vein endothelial cells, reduce inflammatory cell aggregation by influ-
encing cytokine system and may make apoptotic nerve cells and neuroprotective 
component in glial cells. (Folia Morphol 2019; 78, 1: 17–23)
Key words: spinal cord injury, Potentilla fulgens, vascular endothelial 
growth factor (VEGF), B-cell lymphoma 2 (Bcl-2)
INTRODUCTION
Most spinal cord lesions are seen on the cervical 
spine, while devastating motor, sensory and auto-
nomic dysfunctions are causing issues for spinal cord 
injury (SCI) cervical, thoracic, lumbar, and sacral lev-
els under injury [3]. Disturbing lesion in spinal cord 
starts an enormous resistant reaction which may 
bring about the apoptosis of neurons and the initia-
tion of glial cells, and the neurological dysfunction. 
Lesion to the spinal cord prompts irreversible loss of 
neurons [13, 36].
It has been demonstrated that this useful revamp-
ing within the dorsal horns comes about because 
of excessive and non-specific growing of essential 
afferent sensory fibres and loss of supraspinal innerva-
tions/neurons after lesion [18, 22]. It has additionally 
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been demonstrated that bruise SCI prompts expanded 
abundance and broad spreading of essential afferents 
and that a decrease in the abundance of sensory 
nerve cells is related to reduced pain after SCI [6]. The 
pathological procedure of SCI can be partitioned into 
two phases: essential lesion and subordinate lesion. 
Essential lesion happens instantly after the underlying 
lesion, and its pathological procedures incorporate 
demyelination of the spinal cord and necrosis of the 
neurons and nerve cells [45].
Subordinate lesion happens all through the dis-
ease, and its pathological procedures incorporate 
demyelination, axonal and neuronal necrosis, sensory 
tissue ischaemia and oedema, oxidative compression, 
inflammatory response, and glial scar development 
[12, 26, 32, 37, 43]. The essential injury is privately 
limited to the territory of the vertebral fracture and is 
distinguished by intense haemorrhage and ischaemia. 
Subordinate trauma within the first week after the 
lesion is distinguished by further destruction of neu-
ronal and glial cells, and leads healing to a remarkable 
extension of the injury, with the goal that the paralysis 
can reach out to higher sections.
Oxygen-derived free radicals have been embroiled 
in the pathogenesis of spinal cord neuronal lesion 
after injury. Reducing the level of oxidative compres-
sion limits the subordinate destructive impact after 
disturbing lesion. After spinal cord lesion, loss of 
motor, sensory and autonomic sensory system capac-
ities, muscle spasms, chronic pain, and urinary tract 
diseases may happen [1]. Both practical (locomotor 
capacity and bladder function) and histological pa-
rameters (tissue sparing, axonal sparing, astrogliosis, 
inflammation and BSCB permeability) was enhanced 
by healing with imatinib following spinal cord weight-
drop lesion [2].
Potentilla fulgens is an alpine plant of Western 
Himalayas which is devoured in all parts of the world 
for its promising therapeutic properties. Pharma-
cologically, the aerial and root parts of the plant 
are accounted for to have antioxidant, antitumor, 
hypoglycaemic and antihyperglycaemic components 
[3, 19, 40]. 
Vascular endothelial growth factor (VEGF) is 
among the essentially upregulated genes found in 
SCI rats with allodynia [29]. Apoptosis has a notewor-
thy part in the component of the disturbing lesion 
in the juvenile brain and is extremely serious in the 
brain of 7-day-old rats [28]. A few examinations have 
exhibited that over-expression of B-cell lymphoma 2 
(Bcl-2) keeps neurons from cell death incited by free 
radicals [38], hypoxia [39] or development factor 
deprivation [23]. The neuroprotective impact of 
P. fulgens on neuronal and angiogenetic function 
after spinal cord injury was examined.
MATERIALS AND METHODS
Animals and experimental design
Every single surgical methodology and the con-
sequent care and healing of the animals utilised as 
a part of this investigation were in strict understand-
ing with the National Institutes of Health (NIH Pub-
lications No. 8023, revised 1978) rules for animal 
care. All techniques performed in this examination 
were approved by the Ethics Committee for Animal 
Experimentation of the Faculty of Medicine at Dicle 
University in Turkey. Thirty male Sprague-Dawley rats 
(200–230 g) were kept up under 22 ± 1°C and 12 h 
light/grey cycles with ad libitum access to standard 
pelleted nourishment and water. The 30 rats were 
separated into three groups as a control group, SCI 
group and SCI + P. fulgens treated group (400 mg/ 
/kg/day, i.p.) [24].
The rats of the control (n = 10) and the SCI groups 
(n = 10) were administered 1.5 mL physiologic saline 
solution subcutaneously for 7 days as it were. The rats 
of all groups were kept up in a similar situation and 
ate a similar sort of food. All rats toward the finish of 
the analysis were healthy and no distinction in nour-
ishment/water consumption and body weight pick up 
amongst experimental and control rats were noticed.
Spinal cord injury model
Experimental rats were anesthetised intraperitone-
ally with ketamine and chlorpromazine 75 mg/kg and 
1 mg/kg, separately [42]. Every rat was then positioned 
on a heating pad in a prone position and a rectal test 
was embedded. Under aseptic conditions, following 
T5-12 midline skin incision and paravertebral muscle 
dissection, spinous procedures and laminar arcs of 
T5-12 were evacuated. The particular relative an-
gulation of the spinous procedures of the T9, 
T10, and T11 vertebrae was utilized as an imper-
ative intraoperative landmark: T9 points caudal-
ly, T10 points directly dorsal, and T11 points ros-
trally. This delivers a solid “triangle”’ introduction 
that can be promptly checked whether the animal 
is positioned flat on the operating table. After the 
T11 and T12 vertebrae had been distinguished, 
a laminectomy was performed at T11 and T12 with 
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Friedman-Pearson rongeurs. The clasp was then held 
open with a clasp utensil, with the lower cutting edge 
of the clasp passed extradurally completely around 
the spinal cord and nerve roots at the intersection 
between the T11 and T12 vertebrae, comparing 
to the L1-L2 spinal cord segmental level. The clasp 
was then quickly discharged from the tool to deliver 
a bilateral impact force and sustained dorsal-ventral 
compression. The compression of the spinal cord was 
kept up for 60 s before expulsion of the clasp. The 
muscles were then sutured utilising 3-0 polyglactin 
sutures, and the skin was shut with Michel clips [27]. 
Following surgical system, the rats were put in warm-
ing chamber and their body temperatures were kept 
up at roughly 37°C until the point when they were 
totally conscious. An hour after the spinal cord injury 
in the exploratory groups, saline only was injected 
intraperitoneally in rats of the SCI group.
After spinal cord injury, P. fulgens (400 mg/kg/day, 
i.p.) was administered intraperitoneally in rats of the SCI 
+ P. fulgens treated group during 7 days. Toward the fin-
ish of the examination, the animals were sacrificed uti-
lising a decapitator (Harvard Apparatus, Holliston, MA, 
USA). The 30 rats were partitioned into three groups as 
control, SCI and SCI + P. fulgens treated groups (400 
mg/kg/day, i.p.). Each group had 10 animals. All of 
them were utilised for biochemical parameters and the 
assessment of histological examination in each group.
Histologic examinations
The specimens taken from the spinal cord were 
fixed with neutral buffered 10% formalin solution. 
Spinal cord specimens were directly dehydrated in an 
evaluated solution of ethanol and implanted into par-
affin wax; 5 mm sections were cut with a microtome 
(Rotatory Microtome, Leica, RM 2265, Germany) and 
mounted on the smeared slides. The segments were 
stained with heaematoxylin and eosin in order to 
describe the white and the grey matter, separately.
Immunohistochemical staining
An antigen-retrieval process was performed in cit-
rate buffer solution (pH 6.0) two times: first for 7 min, 
and afterward for 5 min in a microwave oven at 700 W. 
They were permitted to cool to room temperature 
for 30 min and washed in distilled water twice for 
5 min. Endogenous peroxidase action was hindered 
in 0.1% hydrogen peroxide for 15 min. An ultra 
V block (Histostain-Plus Kit, Invitrogen, Carlsbad, CA) 
was connected for 10 min before the use of the pri-
mary antibodies (VEGF antibody, mouse monoclonal, 
1/200, SantaCruz Biotechnology) and Bcl-2 antibody 
(mouse monoclonal, 1/100, Abcam) overnight.
The secondary antibody (Histostain-Plus Kit, In-
vitrogen, Carlsbad, CA) was connected for 15 min. 
At that point, the slides were exposed to streptavi-
din-peroxidase for 15 min. Diaminobenzidine (DAB, 
Invitrogen, Carlsbad) was utilised as a chromogen. 
Control slides were set up as specified above yet 
overlooking the primary antibodies. In the wake of 
counterstaining with haematoxylin, washing in tap 
water for 5 min, and in refined water for 2 × 5 min, 
the slides were mounted.
Measurement of MPO activity
The myeloperoxidase (MPO) activity levels were 
measured using the method described by Hillegass 
et al. [17]. Spinal cord tissue specimens were homog-
enised in 50 mM potassium phosphate buffer with 
a pH of 6.0 and centrifuged at 41,400 g for 10 min. 
The pellets were then suspended in 50 mM PB con-
taining 0.5% hexadecyl trimethyl-ammonium bromide 
(HETAB). After three freezes and defrost cycles, with 
sonication between cycles, the samples were centri-
fuged at 41,400 g for 10 min. Aliquots (0.3 mL) were 
added to 2.3 mL of the response mixture containing 
50 mM PB, o-dianisidine, and 20 mM H2O2 solution. 
One unit of enzyme action was characterised as the 
measure of MPO presence that caused an adjustment 
in absorbance, estimated at 460 nm for 3 min. MPO 
action was expressed as U/g tissue.
MDA and GSH assays
Spinal cord tissue samples were homogenised 
with super cold 150 mMKCl for the assurance of 
malondialdehyde (MDA) and glutathione (GSH) levels. 
The MDA levels were tested for the products of lipid 
peroxidation and the outcomes are expressed as nmol 
MDA/g tissue [20]. 
Glutathione was resolved by a spectrophotomet-
ric technique in light of the utilisation of Ellman’s 
reagent and the outcomes are expressed as μmol 
GSH/g tissue [10].
Statistical analysis
All information is expressed as means ± standard 
deviation. Groups of information were contrasted and 
an analysis of variance (ANOVA) trailed by Tukey’s 
various correlation samples. Estimations of p < 0.05 
were considered as significant.
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Positive VEGF expression was likewise found in 
some nerve cells and glial cells. In the SCI + P. fulgens 
treated group, VEGF expression in the vascular en-
dothelium was positive. Conversely, it was feeble 
in the glial cells and a portion of the radicular and 
funicular cells in the grey and the white matter. In 
the control group of Bcl-2 expression, negative Bcl-2 
immunoreaction was seen in the radicular-funicular 
nerves and the glial cells. In the SCI group, positive 
Bcl-2 immunoreaction was seen in apoptotic cells, 
in minor unipolar neurons, and in glial cells. In SCI 
+ P. fulgens treated group, apoptotic changes were seen 
in bipolar and unipolar neurons, yet Bcl-2 expression 
surfaces were not as much as the SCI group (Fig. 1).
DISCUSSION
Spinal cord lesion is typically a disturbing lesion 
to the central nervous system which can bring about 
tissue and motor dysfunction accompanied by molec-
ular and cellular injury after trauma. Spinal cord lesion 
brings about a fast and broad oxidative compression. 
It has for quite some time been built up that oxidative 
compression assumes a significant part in the patho-
physiology of SCI [9, 11, 34]. The utilisation of animal 
models is significant in formulating experimental heal-
ings planned to restore lost functions due to SCI [36].
Receptive astrocytes likewise assume a vital part in 
lesion healing and practical recuperation after SCI. At 
the subacute stage, astrocytes relocate to compact the 
injury, apparently detaching the inflammatory cells to 
keep them from spreading into the parenchyma of the 
spinal cord. Initially, it was believed that the essential 
function of astrocytes was to buffer and supply neu-
rons; however, these days there is a lot of evidence 
demonstrating that astrocytes are firmly connected 
with microglia, oligodendrocytes, and different astro-
cytes in the nervous system. Astrocytes direct neuro-
transmitters, take an interest in synaptogenesis, medi-
ate the antibody, express extracellular matrix molecules, 
advanced cell migration, and advanced separation and 
development of the central nervous system [4].
Apoptosis causes the death of neuronal cells, par-
ticularly neurons and oligodendrocytes in the spinal 
cord after lesion, and further upsets and annihilates 
the axon-myelin anatomical unit and disables impulse 
conduction, bringing about neuronal loss [33, 34]. 
A period course investigation in rats uncovered that 
apoptosis happened as ahead of schedule as 4 h post 
lesion and could be seen in decline amount as late as 
3 weeks after SCI. After SCI, caspase initiation hap-
Table 1. Biochemical results according to the study groups
Control SCI SCI + P. fulgens
MDA [nmol/g] 30.45 ± 0.72 47.64 ± 0.66** 33.24 ± 0.82++
GSH [µmol/g] 2.65 ± 0.08 1.84 ± 0.04* 2.62 ± 0.07++
MPO [U/g] 4.52 ± 0.02 7.82 ± 0.62** 7.92 ± 0.28+
Values are presented as mean ± standard deviation. Each group consists of 10 rats. 
GSH — glutathione; MDA — malondialdehyde; MPO — myeloperoxidase; SCI — spinal 
cord injury 
*p < 0.05, versus control; **p < 0.001 vs. control; +p < 0.01, SCI + P. fulgens treated 
group; ++p < 0.001, SCI + P. fulgens treated group
RESULTS
In this study, control, SCI and SCI + P. fulgens treat-
ed groups were analysed as far as biochemical data. 
MPO action, which is acknowledged as an indicator 
of neutrophil infiltration, was fundamentally higher 
in the spinal cord tissues of disturbed rats than those 
of the control group (p < 0.001). P. fulgens healing 
fundamentally reduced spinal cord tissue MPO levels 
(p < 0.01). The injury caused a noteworthy increment 
in the MDA levels (p < 0.001) with an attending re-
duction in GSH levels (p < 0.001). P. fulgens healing 
fundamentally decreased the increase in MDA levels 
and reestablished the GSH content at day 7 (Table 1).
In spinal cord samples of the control group, the nu-
clei of multipolar neurons with polygonal appearances 
in the foremost part of the grey matter layer demon-
strated rough chromatin and the nerve expansions were 
scattered in parallel. Glial cells with oval nuclei were seen 
in the white matter and the axonal and dendritic expan-
sions were orderly. In the SCI group, mononuclear cell 
infiltration was seen around the vessels, and in addition 
dilatation and discharge of the veins were seen along 
the pia mater and in the veins, in the foremost medi-
an fissure of the spinal cord. Degenerative changes in 
a portion of the multipolar and bipolar nerve cells and 
pyknotic changes in the nuclei of glial cells were noticed.
The histopathological examination of SCI + P. fulgens 
treated groups uncovered minor haemorrhagic sec-
tions with decreased inflammatory cells in the grey 
and the white matter, slight degeneration in multipo-
lar and bipolar cells, and hypertrophic glial cells were 
likewise noticed. Immunohistochemical examinations 
of the control group indicated VEGF positive expres-
sion in the assortments of multipolar neurons in the 
foremost part of the spinal cord while it was some-
what expressed in minor fine and vascular endothelial 
cells. In the spinal cord lesion injury, expanded VEGF 
expression was seen in the endothelial cells of vessels 
in the grey and the white matter layers.
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pens in neurons at the lesion site within hours, and 
in oligodendrocytes neighbouring, and far off from, 
the lesion site over a time of days. The long duration 
neurological shortages after spinal cord lesion might 
be expected to a limited extent to induce extensive 
apoptosis of neurons and oligodendroglia is caused 
by lesions in distant and often unaffected areas [8].
Özevren et al. [30] found that P. fulgens may ame-
liorate nerve cell injury after traumatic brain lesion, 
contingent upon the measure of application. VEGF 
is a contributing component in the advancement of 
vascularisation amid angiogenesis and spinal cord 
lesion. In any case, the neuroprotective mechanism 
of VEGF is as yet uncertain. A few examinations have 
demonstrated that the administration of VEGF to 
the wounded spinal cord has neuroprotective effect, 
induces angiogenesis and enhances neurobehavioural 
outcomes [25, 31].
Herrera et al. [16] demonstrated that VEGF is 
regularly expressed in neurons and astrocytes. They 
observed that neurons at the site of lesion 1 day after 
spinal cord lesion were significantly lost and could 
add to a general reduction in VEGF. After spinal cord 
lesion, VEGF expression was seen in some nerve cells 
and glial cells, an expansion in VEGF immuno-re-
sponse in vascular endothelial cells was noticed. For 
this situation, angiogenesis was believed to be actu-
ated in endothelial cells after lesion. One investigation 
demonstrated that the over-expression of Bcl-2 by 
gene transfer or in transgenic mice decreased infarc-
tion after permanent and transient central ischaemia. 
Expression of the apoptosis-inhibitory Bcl-2 gene 
Figure 1. A. Control group. The nuclei of multipolar neurons with polygonal appearances at the front of the grey matter layer shows coarse 
chromatin (red arrow) and the nerve extensions are distributed in parallel, the round nucleus of the glial cells (yellow arrow) in the white matter, 
the axonal and the dendritic extensions are regular (haematoxylin-eosin staining, bar 50 µm); B. Spinal cord injury (SCI) group. Dilatation and 
haemorrhage in a blood vessel (yellow arrow), degeneration and nuclear pyknosis in radicular (black arrow), funicular neuron cells (red arrow) 
(haematoxylin-eosin staining, bar 50 µm); C. SCI + P. fulgens treated group. Small haemorrhagic segments (yellow arrow) with reduced inflam-
matory cells in the grey and the white matter, slight degeneration in multipolar (red arrow) and bipolar cells (black arrow), and hypertrophic glial 
cells (green arrow) (haematoxylin-eosin staining, bar 50 µm); D. Control group. Vascular endothelial growth factor (VEGF) positive expression in 
multipolar neurons (yellow arrow) and vascular endothelial cells (red arrow) (VEGF immunostaining, bar 50 µm); E. SCI group. An increase in VEGF 
expression in endothelial cells (yellow arrow), positive VEGF expressions in some nerve cells and glial cells (red arrow) (VEGF immunostaining, 
bar 50 µm); F. SCI + P. fulgens treated group. Positive VEGF expression in the vascular endothelium (red arrow), weak VEGF expression in glial 
cells (yellow arrow) and some of the radicular and funicular cells (black arrow) (VEGF immunostaining, bar 50 µm); G. Control group. Negative 
B-cell lymphoma 2 (Bcl-2) immuno-reaction in radicular-funicular nerves (red arrow) and glial cells (yellow arrow) (Bcl-2 immunostaining, bar 
50 µm); H. SCI group. Positive Bcl-2 expression in apoptotic cells, small unipolar neurons (red arrow) and glial cells (yellow arrow) (Bcl-2 im-
munostaining, bar 50 µm); I. SCI + P. fulgens treated group. Decrease in the quantity of Bcl-2 expression in unipolar neurons (red arrow), and 
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under the control of tissue particular promoters has 
turned out to be equipped for shielding different sorts 
of cells from apoptosis, especially motor neurons of 
the spinal cord [7].
The glutathione/glutathione disulphide (GSH/
GSSG) redox framework is a noteworthy contribu-
tor to the upkeep of the cellular thiol redox status. 
Confirmation demonstrated that the decrease in cell 
GSH was related to upgraded cellular apoptosis while 
increments in GSH were related to the expression of 
the anti-apoptotic enzyme, Bcl-2 [15]. As indicated 
by the outcomes of this investigation, reduction in 
apoptotic cell quantity of nerves and glial cells, and 
furthermore reduction in the Bcl-2 immunoreactivity 
was considered as an indication of cell upturn in 
apoptosis mechanism.
Tas et al. [41] found that neuronal injury impacted 
astrocytes in the blood-brain obstruction and initi-
ated cellular apoptosis. Kanno et al. [21] found that 
autophagic cell death was incited in the wounded 
tissue after SCI and plainly added to neural tissue 
injury after SCI.
After spinal cord lesion, inflammation of the spi-
nal cord and impeded vascular structure, apoptotic 
changes of neurons, and dynamopathic healing are 
a vital procedure. At the point when apoptosis of 
neurons and glial cells is counteracted after lesion, 
the loss of nerve tissue can be fundamentally lessened 
and spinal cord lesion may improve. Inflammatory 
reactions are a noteworthy component of the sec-
ondary lesion and they are supposed to play a key 
role in controlling the pathogenesis of intense and 
chronic SCI and appear to play a significant role in 
nerve injury and in addition add to the control of the 
regenerative reaction [14]. In the interim, inflamma-
tory reactions may bring about apoptosis of neurons 
and oligodendrocytes and also scar formation and 
lastly the decrease in neuronal capacity [35]. Hence, it 
is believed that decreasing inflammation could reduce 
subordinate degeneration and functional impairment 
after SCI.
CONCLUSIONS
All in all, P. fulgens administration after SCI re-
duced apoptotic cell quantity of nerves and glial 
cells. Since it impacted the cytokine mechanism, it 
supposedly decreased the quantity of inflammatory 
cells and incited angiogenetic advancement. With the 
distinguishing proof of mechanisms that counteract 
spinal cord inflammation and apoptosis, come new 
methodologies for avoiding and treating SCI. Be that 
as it may, there is no present strategy for healing of 
SCI. There is a need for more experimental examina-
tions on the dose quantity and span of healing of 
P. fulgens in SCI. Thusly, therapeutic impact on SCI 
will be better comprehended later on.
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